Advanced Solid Malignancies Completed Phase 1 Trials for Olaparib (DB09074)

Also known as: Advanced Solid Malignancy

IndicationStatusPhase
DBCOND0034803 (Advanced Solid Malignancies)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01813474Investigate the Safety and Tolerability of Olaparib Tablet in Japanese Patients With Advanced Solid MalignanciesTreatment
NCT00572364Open Label, Dose Escalation Phase I Study of AZD2281Treatment